I Q 10mil lots Q 0.20. See who dare to sell to me.

Easy money. Now paper gain 10K. easy money

Just small drop, will rebound and break new high.

Yeah. I hook 500lots at 0.22.

THIS IS JUST THE BEGINING OF THE WORST.

Should i sell my VS now ? I got 80lots cost @1.50.

Walao. What happened to VS ? Another ATAIMS ?

Zelan go go go. Huat Ya

Waoooo. MMC privatise at RM2.00 per share. Zelan sure limit up tomorrow.

Zelan tomorrow 30sen !

MMC share price expect to limit up tomorrow morning. Zelan should follow limit up.

MMCCORP is ZELAN controlling shareholder !

KUALA LUMPUR (June 3): MMC Corp Bhd, whose share price has soared nearly 30% over the past two weeks, is said that its controlling shareholders intend to take the conglomerate private through selected capital repayment.

The group’s shares and warrants have been suspended from trading at the noon break. It climbed 10 sen in the morning trading session.

Market talk has it that the diversified group, which has not been undervalued, is subject to a privatisation exercise via a selective capital reduction of about RM1.80 to RM2 per share.

Sources familiar with the exercise said the privatisation is to pave the way for a bigger restructuring exercise that could involve the listing of its port business.

MMC Corp shares were last traded at RM1.30, valuing it at RM3.96 billion.

i think risk very high to enter now. those insider cost only less than 10sen.

Tan Sri Lee may sell MINDA anytime.

Widad is Dataprp controlling shareholder. Dataprp limit up, Widad will follow. Please monitor closely.

No worry. Buy and hold. Wait good news out. Dun look at 1-2 sen up and down. Aim 50%-100% gain.

If DNEX win Silterra. Share price worth at least 50sen i think.

DNEX is government link stocks. Khazanah likely sell Silterra to Dnex.

Dun forget put Pinepac into your watchlist. Target RM2.00. hehe

Pinepac share price telling you that something good is happening soon. Now share price near 2 year high.

Miss to buy CYMAO. Then buy Pinepac. Same goreng kaki. Pinepac target RM2.00

I pray Pinepac will pay 30sen dividend.

Pinepac testing day high.

PINEPAC RM120 Million cash on hand. Can buy glove business and give special dividend.

KPS and JAKS rose very much recently. PUNCAK will be next. 3 of them are same gang.

JAKS-WC 50SEN $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

JAKS-WC 50sen $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

JAKS-WC 50sen ........................................................................................................

50sen

Everyone buy JAKS together, we made money together !

JAKS-WC worth 50sen at least !

Should limit up soon after the announcement.

If target is rm1.60, still got huge upside. i also bought some at 95sen. Hope can sell at rm1.60 next week.

many ppls dun know why KPS up so much.

wish Novamsc can break 13.5sen today ! pray for it

Next week 15sen !

Let me setup the link first. Then let u all know.

We can discuss the potential undervalued stock and goreng together.

Who interest to join a stock goreng group can pm me.

we can set up a group to goreng stock.

You all see TDEX already 18sen. TDEX and Novamsc start almost at same time.

30sen stock selling at 10sen.

Sep 2020 – EyRIS was awarded a 5-year contract for the deployment of SELENA+, an deep learning system to detect diabetic retinopathy, glaucoma and age-related macular degeneration in the Singapore Integrated Diabetic Retinopathy Program (SiDRP). This award is not only a milestone for EyRIS but also a world first in showcasing real world adoption of an artificial intelligence medical device in a national screening program.

SELENA+ attained its regulatory approval by the Singapore’s Health Science Authority (HSA) in Oct 2019, European CE Mark in March 2020 and Medical Device Authority of Malaysia in June 2020. This award-winning product was recently cited as one of five projects to be implemented under National AI Strategy unveiled by the Singapore government.

When SELENA+ goes live in November 2020, it will be initially deployed to screen 120,000 patients per year. The autonomous AI identifies images that require intervention which was traditionally performed by human graders. This will in turn make the screening process faster and more consistent, translating into reduction of workload and cost savings.

EyRIS’s SELENA+ is also deployed in 23 private optometric practices in Singapore on the “Say No To Vision Loss” platform.

I studied this company in very detail. I found that it is a company with bright prospect. It is really have their expertise and technology.

Bcos of market too bad, if not Novamsc can rise to 20sen.

Hold for long term sure win one. No worry at all.

Singapore government requirement is very very high one. Only world class standard only able get their contract. Novamsc show its world class abilities.

U can buy a world class technology company at price 10sen. It is damn cheap.

This week 30sen sure one.